A core function of the Ontario CRISM node team (OCRINT) is to develop and collaborate on evidence-based guidelines and protocols focused on reducing substance use-related harms and informing health system interventions and related policies. To this end, OCRINT has engaged with the national CRISM team and key stakeholders to undertake a number of evidence-based guidance documents toward effective approaches to substance use screening, treatment, and interventions. The following are a few of these key guidelines.
COVID-19
LCRUG
Clinical Management of OUD
Take-home naloxone
iOAT
Alcohol Use Disorder (AUD)